The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...

Rescription, Inc., a leading innovator in pharmacy benefit management, is proud to announce it has been awarded a U.S.

To add insult to injury, many hospitals that aggressively pursue unpaid medical bills profit from a federal drug discount program: the 340B Drug Pricing Program, which was established to help ...

The federal government has dropped its appeal of a preliminary injunction blocking implementation of the Department of Health and Human Services’ 340B Rebate Model Pilot Program.

Data sovereignty key navigating 340B's future helps healthcare leaders build integrated data systems for compliance and ...

The recent litigation concerning the government’s 340B Rebate Model Pilot Program (the Rebate Program), as further described ...

The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments have ...

Sagebrush Health Services has filed a lawsuit against Amgen, alleging unlawful termination of discounted drug sales under the ...

Amgen is being sued over an alleged unlawful decision to end discounted drug sales to Sagebrush Health Services under the federal 340B Drug Pricing Program. The lawsuit claims the move restricts ...

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...